Emmaus Life Sciences, Inc. (EMMA)
OTCMKTS
· Delayed Price · Currency is USD
0.0145
+0.0005 (3.57%)
At close: Mar 3, 2026
Emmaus Life Sciences Market Cap
Emmaus Life Sciences has a market cap or net worth of $1.02 million as of March 6, 2026. Its market cap has decreased by -82.33% in one year.
Market Cap
1.02M
Enterprise Value
32.41M
Revenue
11.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.01
Market Cap Chart
Since July 18, 2019, Emmaus Life Sciences's market cap has decreased from 353.30M to 1.02M, a decrease of -99.71%. That is a compound annual growth rate of -58.62%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| CERo Therapeutics Holdings | 1.03M |
| Eastgate Biotech | 1.06M |
| Halberd | 1.12M |
| International Stem Cell | 1.13M |
| Evofem Biosciences | 1.14M |
| EV Biologics | 840.53K |
| Vaxxinity | 1.27M |
| Protagenic Therapeutics | 811.84K |